FDA Approves First Oral Medication for Pulmonary Arterial Hypertension
Describes the trial results and subsequent approval of Tracleer.
Bosentan Therapy for Pulmonary Arterial Hypertension
Actelion's slide show presentation to the FDA.
MedlinePlus: Bosentan
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations
Tracleer
Features an overview of pulmonary hypertension, prescribing information for US residents, and press releases.
|